The Mathematician Versus the Malignancy
Elie Dolgin • May 07, 2014
Patients have long received cancer treatments at the maximum tolerated dose on a regular schedule. Could a more sophisticated approach save lives?
Elie Dolgin meets one mathematical biologist whose theories are now being tested in the clinic to see if they can improve the efficacy of today's anticancer arsenal.
Continue reading at Nature Medicine.
Drug trial results show that vaccines aren't the only use for the mRNA technology behind the most widely used COVID-19 jabs.
FDA panel’s green light on glaucoma wearable device offers hope in sight.